In vitro and in vivo percutaneous absorption of catechol

被引:19
|
作者
Jung, CT [1 ]
Wickett, RR
Desai, PB
Bronaugh, RL
机构
[1] US FDA, Off Cosmet & Colors, Laurel, MD 20708 USA
[2] Univ Cincinnati, Div Pharmaceut Sci, Cincinnati, OH 45267 USA
关键词
catechol; percutaneous absorption; skin; penetration; hair dye; rat; human;
D O I
10.1016/S0278-6915(03)00040-1
中图分类号
TS2 [食品工业];
学科分类号
0832 ;
摘要
The Cosmetic Ingredient Review Expert Panel found insufficient data to conclude that catechol could be used safely in permanent hair dye products. Information was lacking on the extent of oxidation and skin absorption of remaining catechol. In vitro percutaneous absorption studies were conducted in human and rat skin using a consumer permanent hair dye spiked with 0.6% catechol. A 30-min application demonstrated 0.4% of the applied dose was absorbed through human skin and 0.2% through rat skin. The minimal absorption observed was due to the short exposure time and to partial oxidation of catechol by the dye developer. The fate of catechol remaining in rat skin after exposure in vitro and in vivo was investigated with additional absorption studies using catechol in ethanol. At 72 h, 24-h application of 4% catechol resulted in skin absorption of 81% of the applied dose in vitro and 53% in vivo. Skin levels measured at 24 h remained unchanged after 72 h. Therefore the skin reservoir did not contribute to the estimated systemic absorption. A deconvolution technique employed to predict skin absorption using plasma levels from intravenous and dermal administration overestimated in vivo skin absorption due to volatility of catechol in an ethanolic vehicle. Published by Elsevier Science Ltd.
引用
收藏
页码:885 / 895
页数:11
相关论文
共 50 条
  • [31] Evaluation of indomethacin percutaneous absorption from nanostructured lipid carriers (NLC):: In vitro and in vivo studies
    Ricci, M
    Puglia, C
    Bonina, F
    Di Giovanni, C
    Giovagnoli, S
    Rossi, C
    JOURNAL OF PHARMACEUTICAL SCIENCES, 2005, 94 (05) : 1149 - 1159
  • [32] In vivo and in vitro percutaneous absorption of cancer preventive flavonoid apigenin in different vehicles in mouse skin
    Li, BY
    Birt, DF
    PHARMACEUTICAL RESEARCH, 1996, 13 (11) : 1710 - 1715
  • [33] IN-VITRO IN-VIVO CORRELATION OF PERCUTANEOUS-ABSORPTION - ISOSORBIDE DINITRATE AND MORPHINE HYDROCHLORIDE
    HATANAKA, T
    KATAYAMA, K
    KOIZUMI, T
    SUGIBAYASHI, K
    MORIMOTO, Y
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 1994, 17 (06) : 826 - 830
  • [34] Percutaneous absorption of piroxicam: In vitro release and percutaneous absorption from different concentration gels
    Ben Mustapha, Rym
    Lafforgue, Christine
    Fenina, Nadia
    JOURNAL OF FOOD AGRICULTURE & ENVIRONMENT, 2010, 8 (3-4): : 90 - 95
  • [35] Factors affecting percutaneous absorption of caffeine in vitro
    Greaves, LC
    Wilkinson, SC
    Williams, FM
    TOXICOLOGY, 2002, 178 (01) : 65 - 66
  • [36] Percutaneous absorption of antisense phosphorothioate oligonucleotide in vitro
    Lee, YM
    Song, K
    Lee, SH
    Ko, GI
    Kim, JB
    Sohn, DH
    ARCHIVES OF PHARMACAL RESEARCH, 1996, 19 (02) : 116 - 121
  • [37] Comparison of in vitro models of percutaneous absorption.
    Pugh, G
    Raabe, HA
    Moyer, GO
    Harbell, JW
    Bagley, DM
    TOXICOLOGICAL SCIENCES, 2003, 72 : 380 - 380
  • [38] In vitro and in vivo percutaneous absorption of seleno-L-methionine, an antioxidant agent, and other selenium species
    Chih-hung Lin
    Chia-lang Fang
    Saleh A Al-suwayeh
    Shih-yun Yang
    Jia-you Fang
    Acta Pharmacologica Sinica, 2011, 32 : 1181 - 1190
  • [39] In vitro and in vivo percutaneous absorption of seleno-L-methionine, an antioxidant agent, and other selenium species
    Lin, Chih-hung
    Fang, Chia-lang
    Al-Suwayeh, Saleh A.
    Yang, Shih-yun
    Fang, Jia-you
    ACTA PHARMACOLOGICA SINICA, 2011, 32 (09) : 1181 - 1190
  • [40] Bicellar systems for in vitro percutaneous absorption of diclofenac
    Rubio, L.
    Alonso, C.
    Rodriguez, G.
    Barbosa-Barros, L.
    Coderch, L.
    De la Maza, A.
    Parra, J. L.
    Lopez, O.
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2010, 386 (1-2) : 108 - 113